Recent Study: Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2014 Update

Boston, MA -- (ReleaseWire) -- 12/10/2014 -- Nanosphere, Inc. (Nanosphere) is a diagnostic company. The company develops molecular diagnostic tests for disease detection and patient treatment. Its products include Verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Nanosphere's Verigene system is used to identify and treat the bacteria and viruses. It offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company's cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.